Common Contracts

Contract

Trial Agreement • August 15th, 2018

• Contract Type
  Trial Agreement
• Filed
  August 15th, 2018

CLINICAL TRIAL AGREEMENTProtocol # LAL-CL02 SMLOUVA O PROVEDENÍ KLINICKÉHO HODNOCENÍProtokol č. LAL-CL02 This Clinical Trial Agreement (“Agreement”) between Synageva Biopharma Corp., with a principal place of business at 33 Hayden Avenue, Lexington, MA 02421 USA, represented by Cristina Oana Stefanescu, DDS, PhD., Acting under Power of Attorney , (“Sponsor”) and INC Research UK Limited with registered offices located in the United Kingdom at Riverview, The Meadows Business, Park Station Approach, Blackwater, Camberley, Surrey GU179AB, UK, acting by s (“INC Research”) Tato smlouva o provedení klinického hodnocení (dále jen „smlouva“) mezi Synageva BioPharma Corp., se sídlem 33 Hayden Avenue, Lexington, MA 02421USA, jednající Cristinou Oanou Stefanescu, DDS, PhD., na základě plné moci, („Zadavatel“) a společností INC Research UK Limited se sídlem ve Spojeném království v Riverview, The Meadows Business, Park Station Approach, Blackwater,Camberley, Surrey, GU179AB, UK, j í (dále jen „